J&J | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
AbbVie USD 3.29B 562M 2025-03
Abbott USD 3.05B 144M 2025-03
Amgen USD 1.69B 191M 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
Baxter International USD 703M 88M 2025-03
Bayer EUR 3.71B 628M 2025-03
Becton, Dickinson and Co. USD 1.27B 45M 2025-03
Biogen USD 572.5M 104.8M 2025-03
Boston Scientific USD 1.6B 15M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
CONMED USD 143M 19.04M 2025-03
Cooper Companies USD 387.9M 3.5M 2025-01
Dexcom USD 310.1M 17.3M 2025-03
Edwards Lifesciences USD 465.7M 26.2M 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
Globus Medical USD 242.8M 10.68M 2025-03
Hologic USD 266.4M 1.4M 2025-03
Indivior 132M 179M 2025-03
Insulet USD 260.6M 400K 2025-03
Integra LifeSciences USD 164M 5.61M 2025-03
Intuitive Surgical USD 563.4M 49.2M 2025-03
J&J USD 5.11B 1.34B 2025-03
Medtronic USD 2.7B 17M 2025-04
Merck USD 2.53B 319M 2025-03
Merit Medical Systems USD 107.49M 4.91M 2025-03
Novartis USD 3.5B 368M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.22B 980M 2025-03
Stryker USD 2.3B 272M 2025-03
Tandem Diabetes Care USD 104.97M 871K 2025-03
Teva Pharmaceutical Industries USD 919M 33M 2025-03
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12
Zimmer Biomet Holdings USD 724.7M 18.8M 2024-12
Zoetis USD 563M 62M 2025-03



J&J Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.